Clinical Trial

Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn about the risk factors and prediction of postoperative venous thromboembolism (VTE) in patients undergoing lung cancer surgery. The main question it aims to answer is: Which clinical, surgical, and laboratory factors are associated with the development of postoperative deep vein thrombosis (DVT) in lung cancer surgery patients, and can machine learning models accurately predict individual risk? Participants undergoing lung cancer surgery will be prospectively followed for 30 days after surgery. Perioperative clinical data, laboratory results, and imaging findings will be collected to identify VTE risk factors and to develop a predictive model.
Trial Details
NCT Number NCT07439991
Lead Sponsor The First Hospital of Jilin University
Conditions Lung Cancer (Diagnosis), Deep Vein Thrombosis (DVT), Venous Thromboembolism (VTE)
Enrollment 900 participants
Start Date 2024-11-01
Primary Completion 2029-11-01 (estimated)
Study Completion 2029-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-27